Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sanjai D. Rao"'
Autor:
Varadan Sevilimedu, Lori L. Davis, Csp# Vast-D Investigators, Peijun Chen, Muhammad Aslam, Ali Iranmanesh, Somaia Mohamed, George Jurjus, James P. Michalets, James Wilcox, Paul B. Hicks, Sidney Zisook, Sanjai D. Rao, Kimberly Lauro, Patricia Pilkinton, Mamta Sapra, Gary R. Johnson, Michael E Thase
Publikováno v:
The Journal of clinical psychiatry. 81(4)
Objective To determine whether concurrent posttraumatic stress disorder (PTSD) should affect whether to augment or switch medications when major depressive disorder (MDD) has not responded to a prior antidepressant trial. Methods Patients at 35 Veter
Autor:
Trisha Suppes, Shabnam I. Thompson, William G. Anderson, Carlos J. Carrera, Muhammed Aslam, Sanjai D. Rao, Julia E. Vertrees, David Lawrence, Mitchell S. Finkel, Timothy M. Juergens, Sidney Zisook, James Wilcox, Joseph Westermeyer, Paul B. Hicks, John Kasckow, Gerardo Villarreal, Sriram Ramaswamy, Ilanit Tal, Clifford S. Nasdahl, Kari A. Jones, Gihyun Yoon, David Loreck, Steven Lieske, K. Ryan Connolly, Somaia Mohamed, James P. Michalets, Gauri Khatkhate, Nicholas Rosenlicht, Patricia Pilkinton, Mamta Sapra, Gary R. Johnson, Michael E Thase, Gunnar Larson, Lori L. Davis, Mary Klatt, Jean Yoon, Thomas P. Beresford, Cristobal A. Nogues, Grant D. Huang, Aimee R. Mayeda, Peijun Chen, Lawrence J. Albers, Julia L. Winston, John T. Little, Solomon S. Williams, Bernard A. Fischer, George Jurjus, Andre Tapp, Ronald Fernando, Beata Planeta, Joseph M. LaMotte, Theresa Gleason, Ali Iranmanesh, D. Cyril D’Souza, Keith D. Anderson, Alexander B. Niculescu, Ayman Fareed, Alexandra Scrymgeour, Sheetal Marri, Kimberly R. Weingart, Robin A. Hurley
Publikováno v:
JAMA. 318(2)
Importance Less than one-third of patients with major depressive disorder (MDD) achieve remission with their first antidepressant. Objective To determine the relative effectiveness and safety of 3 common alternate treatments for MDD. Design, Setting,
Publikováno v:
Clinical Schizophrenia & Related Psychoses. 1:175-180
Clozapine is effective in treatment-resistant schizophrenia, but carries a number of risks, including the rare but potentially fatal complication of cardiomyopathy. We report the case of a long-term inpatient with schizophrenia who improved significa